The rd1 mouse is a model of retinitis pigmentosa, an inherited photoreceptor neurodegenerative disease. In rd1 retina, early onset rod degeneration is caused by a Pde6b mutation that leads to high levels of intracellular cyclic guanosine monophosphate (cGMP). Cyclic nucleotide-gated ion channels (CNGCs), necessary for phototransduction, are regulated by cGMP. We have previously demonstrated that inhibition of dopamine signaling blocks rd1 photoreceptor degeneration in retinal organ cultures. The mechanism underlying this protection remains unknown. The aim of this study was to determine whether inhibition of dopamine signaling alters cGMP accumulation or CNGC expression. Dopamine depletion from rd1 retinal organ cultures resulted in a significant decrease in cGMP compared with untreated rd1 organ cultures. However, cGMP levels in both treated and untreated rd1 organ cultures significantly exceeded cGMP levels in wild-type (wt) retinal organ cultures. The CNGC expression profile was first determined in vivo. Both channel subunits, Cnga1 and Cngb1, are expressed at low levels by postnatal day 2 (P2), increasing sharply by P6 with a modest increase after P12 in wt retina. A similar pattern is seen in rd1 retina until P12 when expression levels decrease, leading to cell death. No significant difference was observed in the expression of either Cnga1 or Cngb1 in organ cultures from wt, rd1, and dopamine-depleted rd1 retinas. Our results show that dopamine depletion significantly decreases cGMP levels in rd1 retinal organ cultures, but that cGMP accumulation remains high, requiring additional mechanisms for photoreceptor protection. These mechanisms may include activation of protein kinase G-signaling pathways and/or crosstalk with dopamine signaling through cyclic adenosine monophosphate pathways.
The rd1 mouse is a model of retinitis pigmentosa, an inherited photoreceptor neurodegenerative disease. In rd1 retina, early onset rod degeneration is caused by a Pde6b mutation that leads to high levels of intracellular cyclic guanosine monophosphate (cGMP). Cyclic nucleotide-gated ion channels (CNGCs), necessary for phototransduction, are regulated by cGMP. We have previously demonstrated that inhibition of dopamine signaling blocks rd1 photoreceptor degeneration in retinal organ cultures. The mechanism underlying this protection remains unknown. The aim of this study was to determine whether inhibition of dopamine signaling alters cGMP accumulation or CNGC expression. Dopamine depletion from rd1 retinal organ cultures resulted in a significant decrease in cGMP compared with untreated rd1 organ cultures. However, cGMP levels in both treated and untreated rd1 organ cultures significantly exceeded cGMP levels in wild-type (wt) retinal organ cultures. The CNGC expression profile was first determined in vivo. Both channel subunits, Cnga1 and Cngb1, are expressed at low levels by postnatal day 2 (P2), increasing sharply by P6 with a modest increase after P12 in wt retina. A similar pattern is seen in rd1 retina until P12 when expression levels decrease, leading to cell death. No significant difference was observed in the expression of either Cnga1 or Cngb1 in organ cultures from wt, rd1, and dopamine-depleted rd1 retinas. Our results show that dopamine depletion significantly decreases cGMP levels in rd1 retinal organ cultures, but that cGMP accumulation remains high, requiring additional mechanisms for photoreceptor protection. These mechanisms may include activation of protein kinase G-signaling pathways and/or crosstalk with dopamine signaling through cyclic adenosine monophosphate pathways. 
Introduction
The rd1 mouse retina was the first identified model of the human retinal degenerative disease retinitis pigmentosa [1] . It is characterized by a mutation in the Pde6b gene [2, 3] , which codes for an enzyme that plays a central role in phototransduction in adult rod photoreceptors. Specifically, in wild-type (wt) photoreceptors, lightstimulated activation of Pde6 through rhodopsin results in breakdown of the second messenger cyclic guanosine monophosphate (cGMP), which in turn causes closure of cyclic nucleotide-gated ion channels (CNGCs) [4] . In rd1 mice, the defect in Pde6 leads to accumulation of cGMP. The rd1 retina contains approximately twice the normal level of cGMP by postnatal day 6 (P6), and differentiating rod photoreceptors begin to undergo cell death around P10 with complete degeneration by P21 [5, 6] . High levels of Ca 2 + influx through CNGCs are thought to initiate cell-death-signaling pathways [5] , although recent reports are consistent with an additional role for cGMP-induced activation of protein kinase G (PKG) in retinal degeneration [7] [8] [9] .
Dopamine is an important neuromodulator in the vertebrate retina that is released by amacrine and interplexiform cells and can diffuse in a paracrine manner to act on every cell type in the retina. It signals through two families of G-protein-coupled receptors, D1 and D2 receptors. Dopamine plays a variety of roles in retinal and cellular processes, including modulation of the trophic effects on retinal development, regulation of circadian rhythms, mediation of light adaptation, and regulation of cyclic adenosine monophosphate (cAMP) [10] .
We have previously shown that inhibition of dopamine signaling through the addition of either D1 or D2 dopamine family receptor antagonists completely blocks rd1 photoreceptor degeneration in retinal organ culture for 4 weeks, whereas photoreceptors are reduced to a monolayer of cells in sham-treated rd1 organ cultures, similar to that seen in in-vivo animals at this age [11] . Protection is also achieved by dopamine depletion using the toxin 6-hydroxydopamine (6-OHDA), demonstrating specific action through dopaminergic pathways. The mechanism underlying this protection is unknown [12] . Here we investigate whether dopamine depletion protects photoreceptors in rd1 retinal organ cultures by suppressing cGMP accumulation or by altering CNGC expression.
Methods

Animals
Retinas of rd1 and wt mice on a C57BL/6 background were used for all experiments. Animals were handled in accordance with the National Institutes of Health Guidelines on Laboratory Animal Welfare, adhering to protocols approved by the Saint Louis University Institutional Animal Care and Use Committee.
Organ cultures
Retinas from wt and rd1 mice were grown in organ culture as described previously [11, 13] . Eyes were enucleated from mice at P2 and incubated in Dulbecco's Modified Eagle's Media (DMEM; Sigma, St Louis, Missouri, USA) plus 1.25 mg/ml fungizone with 0.5% proteinase K (Invitrogen, Carlsbad, California, USA) at 371C for 7 min followed by a brief wash in 10% fetal calf serum (FCS) to halt the enzymatic reaction. Retinas were removed and incubated in DMEM plus 1.25 mg/ml fungizone and 10% FCS to detach retinal pigment epithelium. Retinas were positioned photoreceptor side down on Millipore Millicell-CM cell culture inserts (Millipore, Bedford, Massachusetts, USA) with DMEM/ fungizone/FCS and incubated at 371C in a 5% CO 2 atmosphere. For dopamine-depleted rd1 retinal organ cultures, 100 mM each of 6-OHDA (Sigma) and pargyline (Sigma) were added on the first 2 days in vitro, followed by 50 mM each on days 6 and 7 in vitro (P8 and P9). Media was changed in untreated wt and rd1 organ cultures on the same days that drugs were added to experimental cultures and every 2-3 days for all cultures during the remainder of the culture period.
Retinal organ cultures for cGMP analysis were darkadapted overnight. They were harvested at P14 in total darkness under infrared illumination and immediately frozen on dry ice. Before light exposure, hydrochloric acid was added to lyse cells and stop endogenous Pde activity. Organ cultures were harvested at P10 and immediately frozen on dry ice for quantitative (q)PCR analysis. For all assays, tissue samples were sonicated and stored at -201C.
Cyclic guanosine monophosphate enzyme immunoassays cGMP concentration was determined using the Direct Cyclic GMP Enzyme Immunoassay Kit (Assay Designs, Ann Arbor, Michigan, USA) following the manufacturer's instructions. Samples were diluted 1 : 40 for rd1 retinal organ cultures with or without 6-OHDA treatment and were undiluted for wt cultures. The acetylated format was used in all experiments for additional sensitivity of cGMP levels. Microplates were read using a scanning spectrophotometer (optical density 405 nm). Total protein content of each sample was determined using BCA assays (Pierce, Rockford, Illinois, USA). Data were log-transformed to meet the assumptions of normality required for t-tests.
Welch's one-tailed and two-tailed t-tests were used to determine significance at P less than 0.05.
Real-time polymerase chain reaction
For in-vivo analysis, retinas were harvested at ages between P2 and P21 and immediately frozen on dry ice. Tissue samples were sonicated and stored at -201C. Total RNA was extracted using the Perfectpure RNA Tissue Kit (5 Prime, Gaithersburg, Maryland, USA) according to manufacturer's instructions. One microgram of total RNA was reverse transcribed into cDNA using the Quantitect Reverse Transcription Kit (Qiagen, Valencia, California, USA). qPCR was carried out with SYBR Green dye and specific primer pairs to determine the amplification curve of Cnga1, Cngb1, Hprt, and Actb in 96-well plates on a Chromo4 thermocycler (Bio-Rad, Hercules, California, USA). The following primers were used: Cnga1 forward: AATACGTGGCATTCCTTCGTAAA, reverse: GAGCC ATTGTCATCGTCAGAAA; Cngb1 forward: CAGAGGAG GAACACTACTGCG, reverse: AAGTAATCCATGAGG AGCCAGA; Hprt forward: TCAGTCAACGGGGGACAT AAA, reverse: GGGGCTGTACTGCTTAACCAG; Actb forward: GAAATCGTGCGTGACATCAAAG, reverse: AAG TAATCCATGAGGAGCCAGA. Three independent samples were assayed for each time point and genotype. Three replicates were performed for each sample. The ratio of the Cnga1 and Cngb1 expression level between rd1 and wt mice was calculated by the 2 ÀDDC t method after normalization to Hprt or Actb.
Western blot
Retinas from wt and rd1 mice were harvested at ages between P2 and P21 and homogenized in cold radioimmune precipitation assay buffer. Protein was normalized before separation by SDS-PAGE and transfer onto nitrocellulose membranes. Membranes were blocked with 5% nonfat dry milk in TBST for 2 h at room temperature, incubated with primary antibodies to CNGb1 (Gift from Robert Molday, UBC mouse monoclonal, dilution 1 : 15) or b-actin (mouse monoclonal, dilution 1 : 500, Ab 8226; Abcam) overnight at 41C, and incubated with horseradish peroxidase-conjugated anti-mouse IgG secondary antibodies (rabbit polyclonal, dilution 1 : 5000, A9044; Sigma-Aldrich, St Louis, Missouri, USA) for 1 h at room temperature. After incubation with ECL solution (CPS160, Sigma-Aldrich), the membrane was visualized on a GE LAS4000 imager (GE Healthcare, Pittsburgh, Pennsylvania, USA).
Results and discussion
Dopamine depletion reduces cyclic guanosine monophosphate accumulation in rd1 retinal organ cultures
As the concentration of cGMP in rd1 retinal organ cultures peaks at P14 (data not shown), this age was selected for analysis. The mean cGMP concentration in rd1 retinal organ cultures was B55-fold higher than that in wt retinal organ cultures at P14 (Fig. 1) . These results are consistent with those of previously reported experiments performed in vivo [5, 6] . However in the latter case, the cGMP concentration was about 10-fold higher in the rd1 retina compared with wt. The difference in magnitude is likely due to variance in the retinal organ culture model, including possible cGMP accumulation in the media and loss of some inner retinal neurons. For example, all ganglion cells degenerate when the optic nerve is cut to remove the retina from the organism, reducing the total protein.
Treatment of rd1 retinal organ cultures with 6-OHDA significantly reduced the cGMP concentration compared with that in untreated rd1 retinal organ cultures (Fig. 1 ). This reduction in cGMP is likely due to decreased cGMP synthesis. Dopamine has been shown to regulate cGMP synthesis by acting through the neuromodulator nitric oxide (NO). Our result is consistent with those of experiments in which treatment of rat brain with 6-OHDA resulted in 50% reduction in activity of the NO synthetic enzyme and a consistent, but not significant, decrease in the cGMP level [14] . Further studies on the rat striatum have illuminated a complex downregulation of NO-cGMP signaling in response to 6-OHDA lesions [15] . The NO/cGMP-signaling pathway is widely distributed in the mouse retina [16] and has been shown to play an important role in light adaptation in lower vertebrates [17] . In teleost retina, exogenous dopamine increases NO production and inhibition of D1 receptors blocks lightevoked NO release [18] . Furthermore, activation of the NO pathway inhibits rod cell growth and neurite sprouting in salamander retina [19] , which is consistent with the synaptic defects seen in rd1 retina [20] . Alternatively, decreased cGMP levels could be because of an increase in degradation by other members of the Pde family. However, we are unaware of any evidence to support this hypothesis. In either case, 6-OHDA-treated rd1 retinal organ cultures retained cGMP at levels B45-fold higher than those in wt organ cultures. This result suggests that dopamine depletion may act, in part, to suppress cGMP and increase photoreceptor survival, but that additional effects downstream of cGMP are also required for photoreceptor protection in retinal organ cultures.
Expression of cyclic nucleotide-gated ion channel genes during development of the retina of wild-type and rd1 mice
In the phototransduction cascade, cGMP acts directly on CNGCs, which comprise two subunits in rod photoreceptors, Cnga1 and Cngb1 [4] . However, developmental defects have been identified in the rd1 retina well before initiation of phototransduction [5, 7] . If high levels of Ca 2 + influx induce cell death in rd1 photoreceptors, then CNGCs must be expressed early during photoreceptor cell differentiation. As the developmental time course for Cnga1 and Cngb1 expression has not been reported previously, we first determined the relative expression of each gene in wt and rd1 retinas in vivo between P2 and P21 using qRT-PCR. Both Hprt and Actb (b-actin) were used to control for any potential variability in expression of housekeeping genes during development. We found similar expression patterns between Cnga1 and Cngb1 and either control gene ( Fig. 2a and b, Supplemental Digital Content 1, Fig. S1 , http:// links.lww.com/WNR/A277). In wt retinas, both CNGC genes were detected at P2 with a sharp increase in expression beginning at P6 and continuing through to P12, coinciding with differentiation of rod photoreceptor outer segments. The overall expression pattern is similar to that seen in rhodopsin and other phototransduction genes, with the notable difference being that CNGC expression is evident at P2, whereas rhodopsin expression is first detected at P5 in the mouse retina [21] .
In rd1 retinas, expression of Cnga1 and Cngb1 is comparable with that in wt retinas at early time points; however, this drops sharply beginning around P10-P12 and is nearly absent by P21 ( Fig. 2a and b , Supplemental Digital Content 1, Fig. S1 , http://links.lww.com/WNR/A277). This observation is consistent with the onset of photoreceptor degeneration at P10 and nearly complete loss of rods by P21 [5] . The developmental expression of the Cngb1 protein is consistent with the mRNA expression for both wt and rd1 retinas (Fig. 2c) , although the protein level was below the level of detection before P6. The expression profile of CNGC subunits is consistent with the Ca 2 + influx hypothesis.
Dopamine depletion does not alter cyclic nucleotidegated ion channel expression in rd1 retinal organ cultures
Dopamine signaling mediates changes in gene expression, in part through CREB-mediated activation of transcription factors [22] . As loss of CNGCs has been shown to significantly protect rd1 photoreceptors in vivo [23] , we next determined whether treatment with 6-OHDA alters expression of CNGC subunits in retinal organ cultures. At P10, the age at which rd1 rod cell death begins, we found no significant difference in expression of either Cnga1 or Cngb1 in organ cultures of wt, rd1, or 6-OHDA-treated rd1 retinas (Fig. 3) . Actb was used as a control gene for normalization with eight to nine cultures for each condition (three-way analysis of variance, P = 0.725 and 0.122 for Cnga1 and Cngb1, respectively). We conclude from these results that the neuroprotective effects of dopamine inhibition do not involve CNGC expression.
Conclusion
Our results suggest that dopamine depletion may contribute to protection of rd1 photoreceptors in retinal organ culture through regulation of cGMP levels. Consistent with our results, dopamine inhibition has been established to act through NO to decrease cGMP synthesis in the central nervous system, including the retina, of a variety of species [14, 15, 18] , although the possibility that other members of the Pde family may increase cGMP degradation cannot be eliminated. Nevertheless, additional mechanisms must be essential as the cGMP concentration is only reduced by B18%, yet complete rd1 photoreceptor protection is observed [11] .
Of the three downstream cGMP-specific signaling pathways that are known [24] , two now seem unlikely to explain the protective effects of dopamine inhibition in rd1 retinal organ culture. Specifically, cGMP is known to act in a feedback loop onto Pde6, but this mechanism cannot occur in the rd1 mutants as Pde6 is absent. Second, cGMP can act through activation of CNGCs. Although dopamine signaling is an important transcrip-tional regulator, we found no evidence that dopamine regulates expression of CNGC subunits. We have also demonstrated that the time course of CNGC expression in vivo is consistent with the Ca 2+ influx hypothesis in the rd1 retina, although it does not preclude involvement of other signaling pathways. Additional studies will investigate the possibility that dopamine depletion inhibits CNGC activity in rd1 organ cultures through a novel mechanism.
Two alternative cGMP-signaling pathways warrant further consideration. The third known cGMP-specific signaling pathway is through activation of PKG, although little is known about PKG or its downstream targets in the retina [24] . This is a particularly interesting possibility as a number of mutations causing retinal degenerative disease involve defects in cGMP pathways. A recent study has shown that PKG activity is both necessary and sufficient to cause cGMP-mediated photoreceptor degeneration and that PKG inhibitors are protective in rd1 retina [8] . Finally, high levels of cGMP may induce nonspecific crosstalk with cAMPsignaling pathways [24, 25] . Dopamine signaling acts directly through cAMP, modulating intracellular Ca 2+ levels and mediating antiapoptotic activity in developing rat retina [10, 26, 27] . In conclusion, inhibition of dopamine signaling significantly suppresses cGMP accumulation in rd1 retinal organ cultures, likely acting through NO to inhibit cGMP synthesis; however, this cannot fully account for the protective effects. Further studies are required to determine whether signaling through PKG and/or crosstalk between cGMP and cAMP pathways contribute to the robust photoreceptor protection evident in rd1 retinal organ cultures. . The ratio of mRNA expression level between wt and treated or untreated rd1 organ cultures was calculated by the 2 ÀDDCt method after normalization to Actb. For each condition, nine independent samples were tested. No significant difference in expression was observed among the three conditions. CNGC, cyclic nucleotide-gated ion channel; ctl, control; 6-OHDA, 6-hydroxydopamine; P, postnatal day; wt, wild type.
